BDBM536452 5-(1-(2-((2-chloro-5- morpholinophenyl) amino)-2-oxoethyl)-4- oxo-4,6,7,8-tetrahydro- 1H-dipyrrolo[1,2-a:2',3'- d]pyrimidin-3-yl)-3,4- difluoro-2-hydroxy- benzamide::US11242351, Compound I-31

SMILES NC(=O)c1cc(-c2cn(CC(=O)Nc3cc(ccc3Cl)N3CCOCC3)c3nc4CCCn4c(=O)c23)c(F)c(F)c1O

InChI Key InChIKey=NCVXXLOPDSGPAS-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 536452   

TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Human)
Ontario Institute For Cancer Research (Oicr)

US Patent
LigandPNGBDBM536452(5-(1-(2-((2-chloro-5- morpholinophenyl) amino)-2-o...)
Affinity DataKd:  141nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent